Targeted Genetics Stock Continues Unexplained Rise
November 29, 2006 · Filed Under General
Shares of Targeted Genetics (TGEN) continued to rise on Wednesday gaining more than 13% to $5.39. On Monday, TGEN stock jumped more than 50%. Both days saw a tremendous spike in volume with no detectable news or any other significant events.
Back on November 8th BioHealth Investor suggested that Biogen Idec (BIIB) should buyout TGEN after the biotech giant helped ease the company’s debt levels through a restructuring agreement. Under the agreement BIIB also purchased more TGEN stock.
Could Biogen or any other company be in merger talks with Targeted Genetics?
_
Comments
Leave a Reply
You must be logged in to post a comment.